Cresco Labs Inc. (CSE: CL) (OTC: CRLBF) reported its unaudited financial results for the second quarter. Highlights from the report include its revenue being up 253% year-over-year or reaching $29.9 million, which the company attributed to its expansion into new markets and its growth in the states it already operates.
The company’s second-quarter adjusted EBITDA reached $14.5 million, versus $4.8 million in the same period last year.
Cresco Labs disclosed a net loss of $3.9 million for the quarter, compared to a net income of $1.6 million in the same quarter last year.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
“We delivered an outstanding quarter that reflects the leading positions we have established in some of the most attractive markets in the cannabis industry,” CEO Charlie Bachtell said in a statement. “While our increasing profitability demonstrates our ability to effectively execute and leverage the attractive model we have developed, we continue to operate with a long-term perspective and make investments to position Cresco Labs to lead the cannabis industry in the years to come.”
Cresco Labs traded around $8.36 per share at time of publication.
Don’t miss out on the top cannabis
